🔴 Voyager Therapeutics is trading 5.15% down today, below its September 8 close

Voyager Therapeutics is trading 5.15% down at $3.23, reversing its premarket gain and falling below its September 8 close of $3.40.

• The company presented at the Wells Fargo Healthcare Conference on September 8, highlighting upcoming tau-program data, VY1706 enrollment and NeuroShuttle milestones.
• Available coverage does not identify the presentation as the direct cause; broader markets are also lower, though the move is not clearly market-driven.